Apr 222 minIpsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
Oct 23, 20233 minSkyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small